We are live on ! Find out more
KXA

KPCB XIV Associates Portfolio holdings

AUM $42.8M
1-Year Est. Return 16.52%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
-16.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$23.4M
Cap. Flow
-$2.07M
Cap. Flow %
-1.97%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$2.07M

Sector Composition

Rank Sector Weight
1 Consumer Staples 52.37%
2 Consumer Discretionary 46.88%
3 Industrials 0.76%
4 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COUR icon
1
Coursera
COUR
$1.61B
$54.8M 52.37%
4,635,143
– –
QS icon
2
QuantumScape Corp
QS
$3.19B
$28.7M 27.46%
5,070,532
– –
ISPO
3
DELISTED
Inspirato
ISPO
$14.1M 13.51%
594,505
– –
RENT
4
Rent the Runway
RENT
$107M
$6.19M 5.91%
101,403
– –
AMPX icon
5
Amprius Technologies
AMPX
$1.38B
$793K 0.76%
100,000
– –
OYST
6
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-367,987
Closed -$2.07M

Similar funds

SIP
Scott Investment Partners Henley-On-Thames, United Kingdom $43.5M AUM 17.97% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
JMF
Johnson Midwest Financial Glidden, Iowa $44.7M AUM 21.66% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
HCM
Hawkeye Capital Management Miami Beach, Florida $40.6M AUM 11.3% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

KPCB XIV Associates's Q4 2022 Portfolio in Review

As of Q4 2022, KPCB XIV Associates held 6 positions worth $105M, down 18% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XIV Associates's Q4 2022 filing shows 1 closed position. The largest sale was Oyster Point Pharma, Inc. Common Stock, an estimated $2.07M.

By sector, the portfolio is most concentrated in Consumer Staples at 52% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • KPCB XIV Associates fully exited Oyster Point Pharma, Inc. Common Stock in Q4 2022, selling an estimated $2.07M.
  • KPCB XIV Associates's ten largest holdings make up 100% of its $105M portfolio in Q4 2022.
  • KPCB XIV Associates opened 0 new positions and closed 1 in Q4 2022.
  • KPCB XIV Associates's portfolio value fell 18% quarter-over-quarter to $105M.

Based on KPCB XIV Associates's 13F filing for Q4 2022, filed 7 Feb 2023.